Mike Biotech: Company's new product obtains medical device registration certificate.

On December 1st, Mike Biotech announced that the company's blood type identification and irregular antibody screening quality control products have obtained a medical device registration certificate issued by the National Medical Products Administration. The registration of the new products further enriches the company's product portfolio, which will help enhance the company's overall market competitiveness and have a positive impact on market expansion and future operations. The actual sales of the products covered by the above registration certificate will depend on the future market promotion effect, and it is currently unable to predict the impact of this product on the company's future revenue.